Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease

Saudi Journal of Gastroenterology

Volumn 18, Issue 3, 2012, Pages 201-207

  Ismail, Mona H ^a   Al Elq, Abdulmohsen H ^a   Al Jarodi, Mahdi E ^b   Azzam, Nahla A ^c   Aljebreen, Abdulrahman M ^c   Al Momen, Sami A ^d   Bseiso, Bahaa F ^d   Al Mulhim, Fatma A ^a   Alquorain, Abdulaziz ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b Dammam Medical Complex   (Saudi Arabia)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^d KING FAHAD SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

Bone mineral density; inflammatory bowel disease; osteopenia; osteoporosis; Saudi

Indexed keywords

CALCIUM;

ADULT; AGE DISTRIBUTION; AGED; ANALYZER; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; CORRELATION COEFFICIENT; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR; HUMAN; INDEPENDENT VARIABLE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; OSTEOPENIA; OSTEOPOROSIS; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SAUDI ARABIA; STATISTICAL ANALYSIS; SUPPLEMENTATION; ULCERATIVE COLITIS; WORLD HEALTH ORGANIZATION;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; OSTEOPOROSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SAUDI ARABIA; STATISTICS, NONPARAMETRIC;

EID: 84861696550     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.96458     Document Type: Article

References (44)

1. Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Mühlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1997;92:1157-63 (Pubitemid 27304813)
2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95
3. Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, et al. Non-invasive assessment of bone mineral and structure: State of the art. J Bone Miner Res 1996;11:707-30 (Pubitemid 26172795)
4. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129
5. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9 (Pubitemid 26147662)
6. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: A nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002;156:1-10 (Pubitemid 34680618)
7. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A populationbased cohort study. Ann Intern Med 2000;133:795-9
8. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33 (Pubitemid 27093099)
9. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:1483-90 (Pubitemid 29075187)
10. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Bone mineral density in patients with inflammatory bowel disease: A population-based prospective two-year follow-up study. Scand J Gastroenterol 2004;39:145-53 (Pubitemid 38253626)
11. Compston JE. Review article: Osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995;9:237-50
12. Bernstein CN, Seeger LL, Auton PA, Artinian L, Geffrey S, Goodman W, et al. A randomized placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study. Aliment Pharmacol Ther 1996;10:777-86 (Pubitemid 26340209)
13. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002;37:192-9 (Pubitemid 34102257)
14. Andreassen H, Hylander E, Rix M. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease. Am J Gastroenterol 1999;94:824-8
15. Silvennoinen JA, Lehtola JK, Niemelä SE. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996;31:367-71 (Pubitemid 26117758)
16. Van Hogezand RA, Banffer D, Zwinderman AH, McCloskey EV, Griffioen G, Hamdy NA. Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's Disease. Osteoporos Int 2006;17:535-42
17. Lacativa PG, Farias ML. Osteoporosis and inflammation. Arq Bras Endocrinol Metabol 2010;54:123-32
18. Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am J Med 2009;122:599-604
19. Khawaja AQ, Sawan AS. Inflammatory bowel disease in the Western Saudi Arabia. Saudi Med J 2009;30:537-40
20. Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, Al-Amri SM, Aljebreen AM, Isnani AC, et al. Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh. World J Gastroenterol 2004;10:1341-4 (Pubitemid 39162444)
21. Satsangi J, Silverberg, MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006;55:749-53 (Pubitemid 43764536)
22. Bianchi ML, Baim S, Bishop NJ, Gordon CM, Hans DB, Langman CB, et al. Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents. Pediatr Nephrol 2010;25:37-47
23. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002;77:453-68 (Pubitemid 34465153)
24. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:795-841 (Pubitemid 36268496)
25. Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, et al. Bone mineral density in Iranian patients with inflammatory bowel disease. Int J Colorectal Dis 2006;21:758-66 (Pubitemid 44524030)
26. Poturoglu S, Balkan F, Karaali ZE, Ibrisim D, Yanmaz S, Aktuglu MB, et al. Relationship between bone mineral density and clinical features in patients with inflammatory bowel disease: A local study in Turkish population. J Int Med Res 2010;38:62-8
27. Ezzat Y, Hamdy K. The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases. Int J Rheum Dis 2010;13:259-65
28. Etzel JP, Larson MF, Anawalt BD, Collins J, Dominitz JA. Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines. Inflamm Bowel Dis 2011. [In Press]
29. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease:There is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000;247:63-70 (Pubitemid 30073165)
30. Frei P, Fried M, Hungerbuhler V, Rammert C, Rousson V, Kullak-Ublick GA. Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 2006;73:40-6 (Pubitemid 43800660)
31. Clarke BL, Khosla S. Physiology of bone loss. Radiol Clin North Am 2010;48:483-95
32. Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol 2010;6:82-8
33. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population-based study. Gut 1997;40:313-9 (Pubitemid 27145642)
34. Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-81 (Pubitemid 30305842)
35. Bianchi ML. Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys 2010;503:54-65
36. Orlic ZC, Turk T, Sincic BM, Stimac D, Cvijanovic O, Maric I, et al. How activity of inflammatory bowel disease influences bone loss. J Clin Densitom 2010;13:36-42
37. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000;133:795-9
38. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-7 (Pubitemid 37500422)
39. Harpavat M, Keljo DJ, Regueiro MD. Metabolic bone disease in inflammatory bowel disease. J Clin Gastroenterol 2004;38:218-24 (Pubitemid 38233328)
40. de Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol 2002;97:2011-5
41. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-9 (Pubitemid 24294565)
42. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002;8:87-92 (Pubitemid 34213505)
43. Noble CL, McCullough J, Ho W, Lees CW, Nimmo E, Drummond H, et al. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2008;27:588-96 (Pubitemid 351316781)
44. Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporos Int 1993;3:236-41. (Pubitemid 23252441)